MedPath

A double-blind, randomized, placebo-controlled study of early oseltamivir treatment of influenza in children 1-3 years of age

Conditions
Influenza
MedDRA version: 9.1Level: LLTClassification code 10022000Term: Influenza
Registration Number
EUCTR2007-004734-17-FI
Lead Sponsor
Terho Heikkinen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Objective: ;Primary end point(s): ;Main Objective:
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath